Career Development Program

职业发展计划

• 批准号: 7715196
• 负责人: CLARA D BLOOMFIELD
• 金额: $ 14.97万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2014-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7715196
• 关键词: Academia; Academic Medical Centers; Advisory Committees; Animal Model; Area; Award; Basic Science; Bioinformatics; Biological Markers; Cancer and Leukemia Group B; Clinic; Clinical; Clinical Oncology Supplement (K12); Clinical Research; Clinical Sciences; Clinical Trials; Clinical and Translational Science Awards; Commit; Comprehensive Cancer Center; Consultations; Dental Students; Diagnosis; Disease; Doctor of Philosophy; Education; Educational process of instructing; Eligibility Determination; Engineering; Enrollment; Epidemiology; Etiology; Evaluation; Experimental Leukemia; Faculty; Fellowship; Funding; Future; Gender; Genetic Programming; Goals; Grant; Health; Hematology; Human; Human Resources; Individual; Institutional National Research Service Award; Internal Medicine; Laboratories; Laboratory Scientists; Link; Medical; Medicine; Mentors; Mentorship; Minority; Modeling; Mus; Nurses; Ohio; Patient Care; Patients; Peer Review; Pharmacology; Pharmacy facility; Phase; Physicians; Population; Positioning Attribute; Prevention; Public Health; Qualifying; Recommendation; Recruitment Activity; Reproduction spores; Research; Research Personnel; Research Training; Resources; SECTM1 gene; Science; Scientist; Stereotyping; Subgroup; Therapeutic; Time; Training; Training Programs; Training Support; Training and Education; Translational Research; United States National Institutes of Health; Universities; Veterinary Medicine; Waiting Lists; Woman; Women Physicians; Work; base; cancer genetics; career; career development; college; design; drug development; experience; human disease; interest; leukemia; member; novel diagnostics; novel strategies; novel therapeutics; oncology; population based; post-doctoral training; pre-clinical; pre-doctoral; professor; programs; response; success; therapeutic development; tumor immunology

The Career Development Program (CDP) is an important component of this Leukemia SPORE application and the national SPORE program because it will assure a cadre of academic faculty who are translational scientists dedicated to discover and apply new approaches to understanding the etiology and epidemiology, prevention, diagnosis, treatment and cure of patients with leukemia. The goal of our CDP is to recruit, provide training and guidance {i.e. mentor and develop) and retain academic faculty level physicianscientists, clinician-investigators, and laboratory-based scientists who will dedicate their endeavors to leukemia translational research. Our focus will be primarily on recruitment of assistant professors. We will place special emphasis on recruiting qualified women and minorities. Indeed, all three of the candidates chosen for the first year positions are women and one is a minority. While any area of translational leukemia research will be considered, we will place special emphasis in our areas of strength which include human cancer genetics, animal models and preclinical and clinical experimental therapeutics. The goal will be to fund three positions at $100,000 each for one to three years. Applications will be solicited from all departments and centers at the Ohio State University Comprehensive Cancer Center (OSUCCC) and by the SPORE Administrative Core. They will be screened for eligibility and diversity by the CDP Leader before formal review begins to assure that the pool contains qualified women and minorities. Applications will be judged based on the potential of the candidate, the strength of the proposed research and the appropriateness of the mentors. Applications will be formally reviewed, scored and ranked by members of the SPORE CDP Steering Committee. Final selection will be made by the CDP Leader and SPORE Program Director in consultation with the SPORE Executive Committee. Each position will be funded for one year, with eligibility for a second and third year dependent upon satisfactory annual progress following evaluation by the awardee's co-mentors and the SPORE Executive Committee. The SPORE will provide $150,000 annual funding to the program; $150,000 annually in matching funds will be provided from the OSUCCC. Success of the program will be judged by the quality, of the science generated by the awardees, their success in obtaining external peer reviewed funding, their success in academic advancement and their retention in academia and leukemia translational research.

职业发展计划（CDP）是白血病孢子应用程序的重要组成部分 和国家SPORE计划，因为它将确保一个学术骨干谁是翻译 致力于发现和应用新方法来理解病原学和流行病学的科学家， 白血病的预防、诊断、治疗和治愈。我们CDP的目标是招募， 提供培训和指导（即指导和发展），并留住学术教师水平的医生和科学家， 临床研究人员和实验室科学家，他们将致力于 白血病转化研究。我们的重点将主要放在招聘助理教授。我们将 特别重视招聘合格的妇女和少数民族。事实上，三位候选人 第一年被选中的职位都是妇女，其中一个是少数民族。而任何转化性白血病 我们将特别重视我们的优势领域，包括人类 癌症遗传学、动物模型以及临床前和临床实验治疗。 目标是为三个职位提供资金，每个职位10万美元，为期一至三年。申请将 从俄亥俄州州立大学综合癌症中心的所有部门和中心征集 （OSUCCC）和SPORE管理核心。他们将接受资格和多样性的筛选， CDP领导人在正式审查开始前确保人才库包含合格的妇女和少数民族。 申请将根据候选人的潜力，所提出的研究的强度来判断 以及导师的适当性。申请将被正式审查，评分和排名 SPORE CDP指导委员会成员。最终选择将由CDP领导人做出， SPORE项目总监与SPORE执行委员会协商。每一个位置都将 供资一年，第二年和第三年的资格取决于令人满意的年度进展 由获奖者的共同导师和SPORE执行委员会进行评估。孢子将 每年为该计划提供15万美元的资金;每年将提供15万美元的配套资金， OSUCCC。该计划的成功将由质量来判断，科学产生的， 获奖者，他们在获得外部同行评审资金的成功，他们在学术上的成功， 在学术界和白血病转化研究中的进步和保留。